Advertisement

Demonstration of potent lipid-lowering activity by a thyromimetic agent devoid of cardiovascular and thermogenic effects

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      A potent lipid-lowering thyromimetic (CGS 26214) devoid of cardiac and thermogenic activity was identified based on its ability to preferentially access and bind the nuclear fraction of hepatocytes over that of myocytes in culture. The difference in access achieved with CGS 26214 was at least 100-fold better for hepatocytes than for myocytes. This in vitro hepatoselectivity resulted in a compound with unprecedented in vivo lipid-lowering potency with a minimal effective dose of 1 μg/kg in rats and dogs (~25x that of L-T3). At the same time, CGS 26214 was free of any cardiovascular effects up to the highest dose tested of 25 mg/kg and 100 μg/kg in rats and dogs, respectively.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kannel WB
        • Gordon T
        • Castelli WP
        Role of lipids and lipoprotein fractions in assessing atherogenesis. The Framingham Study.
        Prog Lipid Res. 1981; 20: 339
        • Lipid Research Clinics Program
        The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
        J Am Med Assoc. 1984; 251: 365
        • Blum CB
        • Levy RI
        Current therapy for hypercholesterolemia.
        J Am Med Assoc. 1989; 261: 3582
        • Chait A
        • Bierman EL
        • Albers JJ
        Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts.
        J Clin Endocrinol Metab. 1979; 48: 887
        • Walton UW
        • Scott PJ
        • Dykes PW
        • Davies JWL
        The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 125I-low density lipoprotein in hypothyroidism and thyrotoxicosis.
        Clin Sci. 1965; 29: 217
        • Thompson GR
        • Soytar AK
        • Spengel FA
        • Jahaw A
        • Gavin SJP
        • Myant NB
        Defects of receptor mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.
        in: 7th Ed. Proc Natl Acad Sci USA. 78. 1981: 2591
        • Staels B
        • van Tol A
        • Chan L
        • Will H
        • Verhoeven G
        • Auwerx J
        Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase and low density lipoprotein receptor in rats.
        Endocrinology. 1990; 127: 1144
        • Ness GC
        • Zhao Z
        Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats.
        Arch Biochem Biophys. 1994; 315: 199
        • Buccino RA
        • Spann JR
        • Pool PE
        • Sonnenblick EH
        • Braunwald E
        Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium.
        J Clin Invest. 1967; 46: 1669
        • Goodkind MJ
        • Dambach GE
        • Thyrum PT
        • Luchi RJ
        Effect of thyroxine on ventricular myocardial contractility and ATPase activity in guinea pigs.
        Am J Physiol. 1974; 226: 66
        • Morkin E
        • Flink IL
        • Goldman S
        Biochemical and physiologic effects of thyroid hormone on cardiac performance.
        Prog Cardiovasc Dis. 1983; 25: 435
        • Dillman WH
        Diabetes and thyroid hormone induced changes in cardiac function and their molecular basis.
        Annu Rev Med. 1989; 40: 373
        • Pontecorvi A
        • Robbins J
        The plasma membrane and thyroid hormone entry into cells.
        Trends Endocrinol Metab. 1989; 8: 91
        • Klein I
        Thyroid hormone and the cardiovascular system.
        Am J Med. 1990; 88: 631
        • Emmelot P
        • Bos CJ
        • van Hoeven RP
        • van Blitterswijk WJ
        Isolation of plasma membranes from rat and mouse livers and hepatomas.
        in: 7th Ed. Methods of Enzymology. Vol. 31. Academic Press, New York1974: 75 (Part A)
        • Spindler BJ
        • MacLeod KM
        • Ring J
        • Baxter JD
        Thyroid hormone receptors: binding characteristics and lack of hormonal dependency for nuclear localization.
        J Biol Chem. 1975; 250: 4118
        • Jackowski G
        • Liew CC
        Fractionation of rat ventrical nuclei.
        Biochem J. 1980; 188: 363
        • Kovanen PT
        • Brown MS
        • Goldstein JL
        Increased binding of low density lipoprotein to liver membranes from rats treated with 17α-ethinyl estradiol.
        J Biol Chem. 1979; 254: 11367
        • Stephan ZF
        • Yurachek EC
        Rapid fluorometric assay of LDL receptor activity by Dil-labeled LDL.
        J Lipid Res. 1993; 34: 325
        • Bradford MM
        Rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
        Anal Biochem. 1976; 72: 248
        • Janero DR
        • Burghardt D
        • Feldman D
        Amphiphile-induced heart muscle cell (myocyte) injury: effects of intracellular fatty acid overload.
        J Cell Physiol. 1988; 137: 1
        • Murayama M
        • Goodkind MJ
        Effect of thyroid hormone on the frequency-force relationship of arterial myocardium from the guinea pig.
        Circ Res. 1968; 23: 743
        • Snedecor GW
        • Cochran WG
        7th Ed. Statistical Methods. Iowa Press, Ames, IA1981: 91
        • Underwood AH
        • Emmett JC
        • Ellis D
        • Flynn SB
        • Leeson PD
        • Benson GM
        • Novelli R
        • Pearce NJ
        • Shah VP
        A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity.
        Nature. 1986; 324: 425
        • Oppenheimer JH
        • Schwartz HL
        • Dillman W
        • Surks MI
        Effect of thyroid hormone analogues on the displacement of 125I-l-triiodothyronine from hepatic and heart nuclei in vivo: possible relationship to hormonal activity.
        Biochem Biophys Res Commun. 1973; 55: 544
        • Schwartz HL
        • Trence D
        • Oppenheimer JH
        • Jiang NS
        • Jump DB
        Distribution and metabolism of l- and d-triiodothyronine (T3) in the rat. Preferential accumulation of L-T3 by hepatic and cardiac nuclei as a probable explanation of the differential biological potency of T3 enantiomers.
        Endocrinology. 1983; 113: 1236
        • Brent GA
        The molecular basis of thyroid hormone action.
        New Engl J Med. 1984; 331: 847
        • Darling DS
        • Carter RL
        • Yen PM
        • Welborn JM
        • Chin WW
        • Umeda PK
        Different dimerization activities of α- and β-thyroid hormone receptor isoforms.
        J Biol Chem. 1993; 268: 10221
        • Haba T
        • Sakai Y
        • Koizumi J
        • Miyamoto S
        • Mabuchi H
        • Takeda R
        A case of heterozygous familial hypercholesterolemia associated with hyperthyroidism: effects of triiodothyronine on low-density lipoprotein receptor and cholesterol synthesis.
        Metabolism. 1983; 32: 1129
        • Chait A
        • Kanter R
        • Green W
        • Kenny M
        Defective thyroid hormone action in fibroblasts cultured from subjects with syndrome of resistance to thyroid hormones.
        J Clin Endocrinol Metab. 1982; 54: 767
        • Barker SB
        Mechanism of action of thyroid hormone.
        Physiol Rev. 1951; 31: 205
        • Liverini G
        • Iossa S
        • Barletti A
        Relationship between resting metabolism and hepatic metabolism: effect of hypothyroidism and 24 h fasting.
        Horm Res. 1992; 38: 154
        • Silva JE
        Hormonal control of thermogenesis and energy dissipation.
        Trends Endocrinol Metab. 1993; 4: 25
        • Horst C
        • Hartmut R
        • Seitz HJ
        Rapid stimulation of hepatic oxygen consumption by 3,5-di-iodo-l-thyronine.
        Biochem J. 1989; 261: 945
        • Lanni A
        • Moreno M
        • Cioffi M
        • Goglia F
        Effect of 3,3′-di-iodothyronine and 3,5-di-iodothyronine on rat liver mitochondria.
        J Endocrinol. 1993; 136: 59